新聞集錦
HOME  keyboard_arrow_right  新聞集錦  keyboard_arrow_right  最新消息  keyboard_arrow_right  禮文公司正式成為美國StemBioSys唯一官方授權代理
最新消息
2023/10/07
禮文公司正式成為美國StemBioSys唯一官方授權代理

---------------------------------------即日起,禮文公司將提供StemBioSys公司全系列產品-----------------------------------

 

StemBioSys其專利核心技術為建立幹細胞培養系統–CELLvo Matrix,可模擬人體內生理微環境,藉此產品協助提高間質幹細胞(MSCs)、誘導性多能幹細胞(iPSCs)與其他貼壁細胞之細胞擴增速度與分化。

 

通常研究者進行初代細胞培養使用之細胞擴增工具會導致細胞擴增之效率不佳。StemBioSys提供的產品有以下優點:提供細胞培養的基質為人類來源,可降低細胞對於外在刺激的影響、對於初代細胞(P0)與分化後的成體細胞繼代培養進行優化,適合藥物篩選、分子機制之探討並加強研究者在操作初代細胞培養上的信心。

 

幹細胞的廣泛應用和市場需求使 StemBioSys 能夠將單細胞擴增平台轉變為高質量細胞和細胞擴增工具,並且在未來的臨床應用(GMP)中具有巨大的潛力。

 

                      

 

StemBioSys Announces Mitek Lab Co. LTD as Distributor

For Stem Cell Research Products in Taiwan R.O.C.

 

SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with MITEK LAB CO., LTD to distribute and market StemBioSys products. Mitek will distribute StemBioSys products in Taiwan, R.O.C..

The agreement will cover all StemBioSys existing cell research products. As additional products are added to the StemBioSys portfolio in the future, these will also be included in the distribution agreement, according to StemBioSys President & CEO Bob Hutchens.

Taiwan is a leading country in scientific research and we are delighted to have the opportunity to enter this market and gain meaningful access to it through our partnership with Mitek Lab Co. LTD,” Hutchens said.  Mitek is a recognized life science tool company in Taiwan with deep technical expertise and they carry a full range of complementary products. We are very excited to announce them as our new distributor in this market. We believe that this will be a great partnership for Mitek, StemBioSys and for researchers in Taiwan” he said.

Wreker Pan, CEO of Mitek, said StemBioSys is a unique company that offers innovative products with the highest quality, and it is our great honor to establish a relationship with such company. We all know that making experimental results closer to the clinical condition is the goal for most researchers and bio-companies. The CELLvo™ series products provide an easy way for the expansion and differentiation of stem cells and its differentiated cells, so we are very optimistic about the market potential of this product in drug screening.”

 

About Mitek

Mitek is a professional agent based in Taiwan, R.O.C. In order to align with global industry trends and enhance competitiveness. We have brought in products from numerous overseas companies known for their exceptional expertise, which enables us to assist Taiwanese cell therapy and pharmaceutical companies in offering comprehensive products/services for development and manufacturing.

 

About StemBioSys Inc.

StemBioSys, Inc., a privately held, San Antonio-based biomedical company, manufactures and develops innovative cell and matrix technologies to support a broad range of research applications. The company markets its products globally to the research community under the CELLvo™ brand name. The company also partners with leading researchers around the world to develop new applications using its proprietary technologies.